| |
FOXP3 and B7-H1 Expression
|
*P
|
|---|
| |
Both +
|
One +
|
Both -
| |
|---|
|
Age
| | | | |
|
< 40 years
|
21 (55)♣
|
7 (18)
|
10 (26)
|
0.496
|
|
≥ 40 years
|
10 (45)
|
7 (32)
|
5 (23)
| |
|
Tumor Size
| | | | |
|
<4 cm
|
18 (64)
|
6 (21)
|
4 (14)
|
0.128
|
|
≥ 4 cm
|
13 (41)
|
8 (25)
|
11 (34)
| |
|
◆
Lymph Node Metastasis
| | | | |
|
Negative
|
12 (63)
|
3 (16)
|
4 (21)
|
0.605
|
|
1 to 3
|
4 (33)
|
3 (25)
|
5 (42)
| |
|
4 to 9
|
9 (50)
|
5 (28)
|
4 (22)
| |
|
10 or more
|
5 (56)
|
3 (33)
|
1 (11)
| |
|
Histological Grade (SBR)
| | | | |
|
II
|
9 (30)
|
7 (23)
|
14 (47)
|
<0.001
|
|
III
|
22 (73)
|
7 (23)
|
1 (3)
| |
|
Lymphovascular Invasion
| | | | |
|
Positive
|
20 (56)
|
8 (22)
|
8 (2)
|
0.745
|
|
Negative
|
11 (46)
|
6 (25)
|
7 (29)
| |
|
Her2/neu Status
| | | | |
|
Positive
|
16 (57)
|
7 (25)
|
5 (18)
|
0.487
|
|
Negative
|
15 (47)
|
7 (22)
|
10 (31)
| |
|
ER Status
| | | | |
|
Positive
|
16 (40)
|
10 (25)
|
14 (35)
|
0.017
|
|
Negative
|
15 (75)
|
4 (20)
|
1 (5)
| |
|
PR Status
| | | | |
|
Positive
|
11 (38)
|
7 (24)
|
11 (38)
|
0.054
|
|
Negative
|
20 (65)
|
7 (23)
|
4 (13)
| |
|
Neo-adjuvant Chemotherapy
| | | | |
|
With
|
17 (49)
|
9 (26)
|
9 (26)
|
0.828
|
|
Without
|
14 (56)
|
5 (20)
|
6 (24)
| |
|
Lymphocyte Infiltration
| | | | |
|
Focal
|
10 (38)
|
5 (19)
|
11 (42)
|
0.022
|
|
Moderate
|
9 (47)
|
7 (37)
|
3 (16)
| |
|
Severe
|
12 (80)
|
2 (13)
|
1 (7)
| |
-
Abbreviations: (+ and -) are number of positive and negative patients, ♣Numbers between brackets are the percentages of patients, ◆Two sample had unknown LN+ status, *P values in bold represent a significant data.
